Bank of Montreal
BLCM

Bank of Montreal’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bank of Montreal’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7
Closed – – 5069
2019
Q2 		$0 Buy
7
+6
+600% +$162 ﹤0.01% 5138
2019
Q1 		$0 Sell
1
-56
-98% -$1.87K ﹤0.01% 4883
2018
Q4 		$2K Buy
57
+29
+104% +$1.29K ﹤0.01% 4449
2018
Q3 		$2K Hold
28
– – ﹤0.01% 4426
2018
Q2 		$2K Buy
+28
New +$2.18K ﹤0.01% 4430

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Bank of Montreal's BLCM Position: Q3 2019 in Review

Bank of Montreal sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 7 shares.

Bank of Montreal first reported a position in BLCM in Q2 2018 and held it in 5 quarters. The position peaked at $2K in Q4 2018. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Bank of Montreal reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 7 Bellicum Pharmaceuticals, Inc. shares in Q3 2019.
  • Bank of Montreal first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2018 and held it in 5 quarters.
  • Bank of Montreal's Bellicum Pharmaceuticals, Inc. position peaked at $2K in Q4 2018.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.